home / stock / life / life short
Short Information | aTyr Pharma Inc. (NASDAQ:LIFE)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 1,173,274 |
Total Actual Volume | 10,803,200 |
Short Trends | |
---|---|
Cover Days | 20 |
Short Days | 0 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 58,664 |
Average Short Percentage | 17.80% |
Is there a LIFE Short Squeeze or Breakout about to happen?
See the LIFE Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
06-04-2024 | $1.86 | $1.9 | $1.95 | $1.82 | 268,406 | 35,355 | 13.17% |
06-03-2024 | $1.82 | $1.85 | $1.87 | $1.8 | 289,674 | 69,267 | 23.91% |
05-31-2024 | $1.77 | $1.73 | $1.8726 | $1.71 | 210,054 | 16,682 | 7.94% |
05-30-2024 | $1.69 | $1.76 | $1.83 | $1.65 | 351,641 | 36,512 | 10.38% |
05-29-2024 | $1.79 | $1.68 | $1.8 | $1.66 | 400,222 | 68,505 | 17.12% |
05-28-2024 | $1.82 | $1.79 | $1.86 | $1.715 | 208,122 | 44,828 | 21.54% |
05-24-2024 | $1.8 | $1.8 | $1.8275 | $1.7801 | 113,737 | 31,734 | 27.9% |
05-23-2024 | $1.89 | $1.8 | $1.9 | $1.77 | 396,244 | 92,223 | 23.27% |
05-22-2024 | $1.95 | $1.86 | $1.95 | $1.86 | 292,216 | 44,902 | 15.37% |
05-21-2024 | $2.09 | $1.95 | $2.09 | $1.905 | 387,818 | 54,196 | 13.97% |
05-20-2024 | $2.01 | $2.07 | $2.09 | $2 | 379,354 | 62,392 | 16.45% |
05-17-2024 | $1.92 | $2 | $2.02 | $1.915 | 577,288 | 136,179 | 23.59% |
05-16-2024 | $1.94 | $1.93 | $1.9685 | $1.8801 | 423,218 | 75,602 | 17.86% |
05-15-2024 | $1.89 | $1.915 | $1.9988 | $1.87 | 489,107 | 87,543 | 17.9% |
05-14-2024 | $1.73 | $1.82 | $1.82 | $1.6901 | 413,516 | 96,699 | 23.38% |
05-13-2024 | $1.72 | $1.7 | $1.75 | $1.68 | 4,636,559 | 21,621 | 0.47% |
05-10-2024 | $1.71 | $1.69 | $1.735 | $1.669 | 224,343 | 59,507 | 26.53% |
05-09-2024 | $1.73 | $1.72 | $1.73 | $1.692 | 214,054 | 29,226 | 13.65% |
05-08-2024 | $1.68 | $1.69 | $1.72 | $1.63 | 271,152 | 63,140 | 23.29% |
05-07-2024 | $1.69 | $1.7 | $1.7099 | $1.64 | 256,475 | 47,161 | 18.39% |
News, Short Squeeze, Breakout and More Instantly...
SAN DIEGO, June 03, 2024 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE) (“aTyr” or the “Company”), a clinical stage biotechnology company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform, today ann...
SAN DIEGO, May 15, 2024 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE) (aTyr or the “Company”), a clinical stage biotechnology company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform, today announced that the c...
Independent data and safety monitoring board (DSMB) recommends continuation of study without any modifications. Findings further support favorable safety profile of efzofitimod. SAN DIEGO, May 14, 2024 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE) (aTyr or the “Compa...